Store

Home | Store | Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
brand-logo

Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022

Publication Date: August 2, 2022

SKU: 22-033

Tags: Pharmaceuticals

Pages: 180

SKU: 22-033

Enhance your understanding of the biopharmaceutical contract manufacturing market with Kalorama Information’s detailed and data-rich report, Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022. Stay ahead of industry trends and make informed decisions with the insights provided in this comprehensive market analysis.

 

Key Highlights:

  • Sales Estimates and Forecasts: Detailed sales estimates are provided for the period from 2016 to 2021, with forecasts extending through 2026. All figures are expressed in current dollars, giving you a clear view of market trends.
  • Third-Party Manufacturing Analysis: Examine the third-party manufacturing landscape for both potential and commercialized prescription drug products worldwide. Potential drug products are those in clinical (Phase I – Phase III) testing, requiring smaller quantities for evaluation, while commercialized drugs have received regulatory approval and are available in mass markets.
  • Regulatory Landscape: Understand the regulatory approvals across different regions, such as the EU and the US, and their impact on the BCMO market.

 

Market Information Included:

  • BCMO Market Trends: Sales estimates from 2016-2021 and forecasts from 2022-2026.
  • Top BCMO Companies: Profiles of leading companies in the BCMO sector.
  • Regional Markets: In-depth analysis of BCMO markets by region, including the U.S., Western Europe, Eastern Europe, China, India, Other Asia, Latin America, and Rest of World.
  • Market Segments: Breakdown of the BCMO market by segment, including Clinical Manufacturing and Commercial Manufacturing.

 

Benefits of This Report:

  • Strategic Insights: Gain a comprehensive understanding of the global BCMO market to inform strategic decisions.
  • Competitive Analysis: Learn about the top players in the industry and their market positions.
  • Market Opportunities: Identify growth opportunities and potential challenges in different regional markets.
  • In-Depth Data: Access detailed market data and forecasts to support business planning and investment decisions.

 

Table: Total Global BCMO Market, 2016–2026, by Service (in billions $)

Year Clinical Manufacturing Commercial Manufacturing Total
2016 $XX Billion $XX Billion $XX Billion
2017 $XX Billion $XX Billion $XX Billion
2018 $XX Billion $XX Billion $XX Billion
2019 $XX Billion $XX Billion $XX Billion
2020 $XX Billion $XX Billion $XX Billion
2021 $XX Billion $XX Billion $XX Billion
2022 $XX Billion $XX Billion $XX Billion
2023 $XX Billion $XX Billion $XX Billion
2024 $XX Billion $XX Billion $XX Billion
2025 $XX Billion $XX Billion $XX Billion
2026 $XX Billion $XX Billion $XX Billion
CAGR 2016 – 2021 XX% XX% XX%
CAGR 2016 – 2026 XX% XX% XX%
CAGR 2021 – 2026 XX% XX% XX%

Source: Kalorama Information

For further details and to purchase directly, please contact us.

Table of Contents

Chapter 1: Executive Summary

The Biopharmaceutical Contract Manufacturing (BCMO) Industry

Scope and Methodology

The BCMO Services Market

  • Figure 1-1: Total Global BCMO Market Growth in $ Billions, 2016 – 2026, by Service

Cell and Gene Therapy

 

Chapter 2: Overview

Introduction

Factors Contributing to the Growth of Contract Manufacturing

Biotechnology

Biosimilars

Cell and Gene Therapies

 

Chapter 3: The Contract Manufacturing Industry

Contract Manufacturing Organizations

The Role of BCMOs

Services Offered by BCMOs

The Rise of CDMOs

Embedded vs. Stand Alone CMOs

Cell and Gene Therapy CMOs

Advancing Technology

Dearth of Intellectual Capital

cGMP Compliance

Quality by Design

SWOT Analysis

Strengths

Opportunities

Weaknesses

Threats

 

Chapter 4: Total Global BCMO Market

Overview

Global Market Forecasts

  • Table 4-1: Total Global BCMO Market in $ Billions, 2016 – 2026, by Service
  • Figure 4-1: Total Global BCMO Market Growth in $ Billions, 2016 – 2026, by Service
  • Table 4-2: Total Global BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Service
  • Figure 4-2: Total Global BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service

Regional Market Overview

  • Table 4-3: Total Global BCMO Market in $ Billions, 2016 – 2026, by Major Region
  • Figure 4-3: Total Global BCMO Market Growth in $Billions, 2016 – 2026, by Major Region
  • Table 4-4: Total Global BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Major Region
  • Figure 4-4: Total Global BCMO Market Growth in $Billions, Biotech Segment, 2016 – 2026, by Major Region

Key Players and Global Market Share

  • Figure 4-5: Major Players in the Global BCMO Market, by Share, 2021
  • Table 4-5: Estimated BCMO Revenues of Major Players in the Global BCMO Market in $Millions, 2021

Cell and Gene Therapy

  • Table 4-6: Cell and Gene Therapy BCMO (in billions of dollars), 2021 and 2026

Future Market Trends

The Future of Pharma and BioPharma Manufacturing

The Future of Contract Manufacturing

 

Chapter 5: The BCMO Market by Region

Introduction

Established Markets

Emerging Markets

The Global BCMO Market by Region

  • Table 5-1: Total Global BCMO Market in $ Billions, 2016 – 2026, Segmented by Region
  • Figure 5-1: Total Regional BCMO Market Growth in $Billions, 2016 – 2026
  • Table 5-2: Total Global BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Region
  • Figure 5-2: Total Regional BCMO Market Growth in $Billions, Biotech Segment, 2016 – 2026

The U.S. BCMO Market

Overview

Market Forecasts

  • Table 5-3: Total U.S. BCMO Market in $Billions, 2016 – 2026, by Service
  • Figure 5-3: Total U.S. BCMO Market Growth in $Billions, 2016 – 2026, by Service
  • Table 5-4: Total U.S. BCMO Market in $Billions, Biotech Segment, 2016 – 2026, by Service
  • Figure 5-4: Total U.S. BCMO Market Growth in $Billions, Biotech Segment, 2016 – 2026, by Service

The Western European BCMO Market

Overview

Market Forecasts

  • Table 5-5: Total Western Europe BCMO Market in $Billions, 2016 – 2026, by Service
  • Figure 5-5: Total Western Europe BCMO Market Growth in $Billions, 2016 – 2026, by Service
  • Table 5-6: Total Western Europe BCMO Market in $Billions, Biotech Segment, 2016 – 2026, by Service
  • Figure 5-6: Total Western Europe BCMO Market Growth in $Billions, Biotech Segment, 2016 – 2026, by Service

The Eastern European BCMO Market

Overview

Market Forecasts

  • Table 5-7: Total Eastern Europe BCMO Market in $Billions, 2016 – 2026, by Service
  • Figure 5-7: Total Eastern European BCMO Market Growth in $ Billions, 2016 – 2026, by Service
  • Table 5-8: Total Eastern Europe BCMO Market in $Billions, Biotech Segment 2016 – 2026, by Service
  • Figure 5-8: Total Eastern European BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service

The Chinese BCMO Market

Overview

Market Forecasts

  • Table 5-9: Total China BCMO Market in $ Billions, 2016 – 2026, by Service
  • Figure 5-9: Total China BCMO Market Growth in $ Billions, 2016 – 2026, by Service
  • Table 5-10: Total China BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Service
  • Figure 5-10: Total China BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service

The Indian BCMO Market

Overview

Market Forecasts

  • Table 5-11: Total India BCMO Market in $ Billions, 2016 – 2026, by Service
  • Figure 5-11: Total India BCMO Market Growth in $ Billions, 2016 – 2026, by Service
  • Table 5-12: Total India BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Service
  • Figure 5-12: Total India BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service

The Rest of World BCMO Market

Overview

Asia

Latin America

Other Countries

Market Forecasts

  • Table 5-13: Total ROW BCMO Market in $ Billions, 2016 – 2026, by Service
  • Figure 5-13: Total ROW BCMO Market Growth in $ Billions, 2016 – 2026, by Service
  • Table 5-14: Total ROW BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Service
  • Figure 5-14: Total ROW BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service

 

Chapter 6: Pharmaceutical & Biotech Company Profiles

3p Biopharmaceuticals

3sbio Group/Shenyang Sunshine Pharmaceuticals Co., Ltd.

Abbvie

Aenova

Agc Biologics

Ajinomoto Bio-Pharma Services

Anemocyte

Asahi Glass Co.

Aurobindo

Avara Pharmaceutical Services

Bachem

Baxter Biopharma Solutions

Boehringer Ingelheim Bioxcellence

Bora Pharmaceuticals

Catalent

Cellipoint Bioservices

Celonic Ag

Charles River Labs/Cognate Bioservices

Cordenpharma

Curia

Cytiva/Danaher

Cytovance Biologics

Dr. Reddy’s Laboratories

Evonik

Excellgene

Fareva

Fresenius Kabi Product Partnering

Fujifilm Diosynth Biotechnologies

Grifols

Idifarma

Jubilant Biosys

Kemwell Biopharma

Lfb Sa

Lonza

Luinabio

Matica Biotechnology/Cha Biotech

Menarini Biotech

Novasep

Lubrizol Life Science Health

Millipore Sigma/Bioreliance/Merck Kgaa

Minaris Regenerative Medicine

Novartis

Oxford Biomedica

Patheon/Thermo Fisher Scientific

Pci Pharma Services

Pfizer Centreone

Piramal Pharma Solutions

Pluristyx

Porton Biologics

Recipharm

Rentschler Biotechnologie Gmbh

Resilience

Rovi Contract Manufacturing

Samsung Biologics

Siegfried Ag

Sl Pharma Labs

Stelis Biopharma/Strides Shashun Ltd.

Stgen Bio

Symbiosis Pharmaceutical Services

Syngene International

Takara Bio

Takeda

Tcg Lifesciences

Teuto

The Center For Breakthrough Medicines

Tianjin Pharmaceutical

Upm Pharmaceuticals

Vetter Pharma International Gmbh

Vibalogics

Woodfield Pharmaceutical

Wuxi Apptec

Yposkesi

Our Knowledge Center provides access to

all market reports